Sumner Michael John
Insider CIK 1936799 · INO Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-05-20 | 2026-05-21 | 9,450 | — | $0 | 18,900 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 37,684 | — | $0 | 37,684 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 46,876 | — | $0 | 46,876 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-05-20 | 2026-05-21 | 2,693 | $1.23 | $3.3K | 42,038 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-05-20 | 2026-05-21 | 9,450 | — | $0 | 44,731 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-05-15 | 2026-05-18 | 2,385 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-05-15 | 2026-05-18 | 680 | $1.30 | $884 | 35,281 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-05-15 | 2026-05-18 | 2,385 | — | $0 | 35,961 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-03-31 | 2026-04-01 | 4,292 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-03-31 | 2026-04-01 | 4,292 | — | $0 | 34,799 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-03-31 | 2026-04-01 | 1,223 | $1.74 | $2.1K | 33,576 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-03-04 | 2026-03-05 | 36,832 | — | $0 | 36,832 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-03-04 | 2026-03-05 | 29,608 | — | $0 | 29,608 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-26 | 2026-02-27 | 11,550 | — | $0 | 23,100 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-26 | 2026-02-27 | 5,010 | — | $0 | 5,009 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-02-26 | 2026-02-27 | 5,010 | — | $0 | 22,860 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-02-26 | 2026-02-27 | 11,550 | — | $0 | 34,410 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-02-26 | 2026-02-27 | 3,903 | $1.79 | $7.0K | 30,507 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-06-30 | 2025-07-01 | 2,916 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-06-30 | 2025-07-01 | 2,916 | — | $0 | 17,850 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-05-20 | 2025-05-21 | 28,350 | — | $0 | 28,350 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-05-20 | 2025-05-21 | 35,100 | — | $0 | 35,100 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-05-15 | 2025-05-16 | 2,385 | — | $0 | 2,385 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-05-15 | 2025-05-16 | 2,385 | — | $0 | 15,614 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2025-05-15 | 2025-05-16 | 680 | $1.95 | $1.3K | 14,934 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-02-27 | 2025-02-28 | 42,900 | — | $0 | 42,900 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-02-27 | 2025-02-28 | 34,650 | — | $0 | 34,650 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-26 | 2025-02-28 | 5,010 | — | $0 | 10,019 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-02-26 | 2025-02-28 | 5,010 | — | $0 | 13,229 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-12-18 | 2024-12-18 | 5,708 | — | $0 | 5,708 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-12-18 | 2024-12-18 | 4,292 | — | $0 | 4,292 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-06-30 | 2024-07-01 | 2,917 | — | $0 | 2,916 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-06-30 | 2024-07-01 | 2,917 | — | $0 | 8,219 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-05-15 | 2024-05-16 | 2,386 | — | $0 | 4,770 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-05-15 | 2024-05-16 | 2,386 | — | $0 | 5,302 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-02-28 | 2024-02-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-02-28 | 2024-02-28 | 15,029 | — | $0 | 15,029 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-06-30 | 2023-07-03 | 35,000 | — | $0 | 70,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-06-30 | 2023-07-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-05-15 | 2023-05-17 | 85,878 | — | $0 | 85,878 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-02-27 | 2023-02-28 | 112,500 | — | $0 | 112,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-06-30 | 2022-07-06 | 105,000 | — | $0 | 105,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-06-30 | 2022-07-06 | 160,000 | — | $0 | 160,000 | SEC↗ |